Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 5, 2006, Pages 939-945

  Sutcliffe, Siobhan ^a   Giovannucci, Edward ^c   Alderete, John F ^d   Chang, Te Hung ^d   Gaydos, Charlotte A ^b   Zenilman, Jonathan M ^b   De Marzo, Angelo M ^b   Willett, Walter C ^c   Platz, Elizabeth A ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ACTININ; IMMUNOGLOBULIN G; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER INCIDENCE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG TOLERANCE; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SEROLOGY; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

ADULT; AGED; ANIMALS; ANTIBODIES, PROTOZOAN; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SEXUALLY TRANSMITTED DISEASES; STATISTICS, NONPARAMETRIC; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS;

EID: 33744750202     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0781     Document Type: Article

References (45)

1. Dennis LK, Dawson DV. Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 2002;13:72-9.
2. Gardner WA, Jr., Culberson DE, Bennett BD. Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 1986;110:430-2.
3. Van Laarhoven PHA. Trichomonas vaginalis, a pathogen of prostatitis. Arch Chir Neerl 1967;19:263-73.
4. Checkoway H, DiFerdinando G, Hulka BS, Mickey DD. Medical, life-style, and occupational risk factors for prostate cancer. Prostate 1987;10:79-88.
5. Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. New York: Springer-Verlag; 2002.
6. Addis MF, Rappelli P, de Andrade AMP, et al. Identification of Trichomonas vaginalis α-actinin as the most common immunogen recognized by sera of women exposed to the parasite. J Infect Dis 1999;180:1727-30.
7. Addis MF, Rappelli P, Delogu G, Carta F, Cappuccinelli P, Fiori PL. Cloning and molecular characterization of a cDNA clone coding for Trichomonas vaginalis α-actinin and intracellular localization of the protein. Infect Immun 1998;66:4924-31.
8. Bricheux G, Coffe G, Pradel N, Brugerolle G. Evidence for an uncommon α-actinin protein in Trichomonas vaginalis. Mol Biochem Parasitol 1998;95:241-9.
9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
10. Sylvestre L, Belanger M, Gallai Z. Urogenital trichomoniasis in the male: review of the literature and report on treatment of 37 patients by a new nitroimidazole derivative (Flagyl). Canad Med Assoc J 1960;83:1195-9.
11. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-6.
12. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003;349:366-81.
13. Krieger JN. Urologic aspects of trichomoniasis. Invest Urol 1981;18:411-7.
14. Alderete JF, Newton E, Dennis C, Neale KA. Antibody in sera of patients infected with Trichomonas vaginalis is to trichomonad proteinases. Genitourin Med 1991;67:331-4.
15. Bozner P, Gombosova A, Valent M, Demes P, Alderete JF. Proteinases of Trichomonas vaginalis: antibody response in patients with urogenital trichomoniasis. Parasitology 1992;105:387-91.
16. Cogne M, Brasseur P, Ballet JJ. Detection and characterization of serum antitrichomonal antibodies in urogenital trichomoniasis. J Clin Microbiol 1985;21:588-92.
17. Kuberski T. Evaluation of the indirect hemagglutination technique for study of Trichomonas vaginalis infections, particularly in men. Sex Transm Dis 1978;5:97-102.
18. Kuberski T. Trichomonas vaginalis associated with nongonococcal urethritis and prostatitis. Sex Transm Dis 1980;7:135-6.
19. Mason PR. Serodiagnosis of Trichomonas vaginalis infection by the indirect fluorescent antibody test. J Clin Pathol 1979;32:1211-5.
20. Romia SA, Othman TA. Detection of antitrichomonal antibodies in sera and cervical secretions in trichomoniasis. J Egypt Soc Parasitol 1991;21:373-81.
21. Sibau L, Bebb D, Proctor EM, Bowie WR. Enzyme-linked immunosorbent assay for the diagnosis of trichomoniasis in women. Sex Transm Dis 1987;14:216-20.
22. Street DA, Taylor-Robinson D, Ackers JP, Hanna NF, McMillan A. Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis in sera and vaginal secretions. Br J Vener Dis 1982;58:330-3.
23. Wos SM, Watt RM. Immunoglobulin isotypes of anti-Trichomonas 7aginalis antibodies in patients with vaginal trichomoniasis. J Clin Microbiol 1986;24:790-5.
24. Bhatt R, Pandit D, Deodhar L. Detection of serum antitrichomonal antibodies in urogenital trichomoniasis by immunofluorescence. J Postgrad Med 1992;38:72-4.
25. Mathews HM, Healy GR. Evaluation of two serological tests for Trichomonas vaginalis infection. J Clin Microbiol 1983;17:840-3.
26. Tawfeek GM, Oteifa NM, el-Gozamy BR. Evaluation of an IgG cystatin capture enzyme-linked immunosorbent assay for the detection of anti-cysteine proteinase antibodies in asymptomatic trichomoniasis patients. J Egypt Soc Parasitol 2003;33:67-83.
27. Salem SA, Azab ME, Safer EH, Aboul-Magd LA. A preliminary study of antibodies against Trichomonas vaginalis infection using the I.F.A.T. J Egypt Soc Parasitol 1981;11:201-6.
28. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 2005;5:149-61.
29. Weston TET, Nicol CS. Natural history of trichomonal infection in males. Br J Vener Dis 1963;39:251-7.
30. Coutts WE, Silva-Inzunza E, Tallman B. Genito-urinary complications of non-gonococcal urethritis and trichomoniasis in males. Urol Int 1959;9:189-208.
31. Drummond A. Trichomonas infestation of the prostate gland. Am J Surg 1936;31:98-103.
32. Watt L, Jennison RF. Incidence of Trichomonas vaginalis in marital partners. Br J Vener Dis 1960;36:163-6.
33. Allen E, Jensen LB, Wood IH. Clinical and bacteriologie observations in Trichomonas vaginitis. Am J Obstet Gynecol 1935;30:565-70.
34. Kucknoor A, Mundodi V, Alderete JF. Trichomonas vaginalis adherence mediates differential gene expression in human vaginal epithelial cells. Cell Microbiol 2005;7:887-97.
35. Krieger JN, Alderete JF. Trichomonas vaginalis and trichomoniasis. In: Holmes K, Sparling P, Mardh P, et al., editors. Sexually transmitted diseases. New York: The McGraw-Hill Companies, Inc; 1999. p. 587-604.
36. De Marzo AM, Meeker AK, Zha S, et al. Human prostate cancer precursors and pathobiology. Urology 2003;62:55-62.
37. Gardner WA, Jr., Culberson DE. Pathology of urogenital trichomoniasis in men. In: Honigberg BM, editor. Trichomonads parasitic in humans. New York: Springer-Verlag; 1990. p. 291-6.
38. Smith CJ, Gardner WA, Jr. Inflammation-proliferation: possible relationships in the prostate. In: Coffey DS, Gardner WA, Jr., Bruchovsky N, Resnick MI, Karr JP, editors. Current concepts and approaches to the study of prostate cancer, progress in clinical and biological research, vol. 239. New York: Alan R. Liss, Inc.; 1987. p. 317-25.
39. Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem J 2003;376:1-14.
40. Yarlett N, Martinez MP, Goldberg B, Kramer DL, Porter CW. Dependence of Trichomonas vaginalis upon polyamine backconversion. Microbiology 2000;146:2715-22.
41. Chen KC, Amsel R, Eschenbach DA, Holmes KK. Biochemical diagnosis of vaginitis: determination of diamines in vaginal fluid. J Infect Dis 1982;145:337-45.
42. Smith RC, Litwin MS, Lu Y, Zetter BR. Identification of an endogenous inhibitor of prostatic carcinoma cell growth. Nat Med 1995;1:1040-5.
43. van der Graaf M, Schipper RG, Oosterhof GO, Schalken JA, Verhofstad AA, Heerschap A. Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer. MAGMA 2000;10:153-9.
44. Garcia AF, Benchimol M, Alderete JF. Trichomonas vaginalis polyamine metabolism is linked to host cell adherence and cytotoxicity. Infect Immun 2005;73:2602-10.
45. Ackers JP, McMillan A, Street DA, Taylor-Robinson D. Trichomonal antibody in male homosexuals. Lancet 1983;1:880.